Suchergebnisse - "Cohen, Myron S"

PubPharm (627)

1

Vaccines that prevent SARS-CoV-2 transmission may prevent or dampen a spring wave of COVID-19 cases and deaths in 2021

enthalten in: bioRxiv.org | 2024

von Swan, D. | Goyal, A. | Bracis, C. | +12

2

What if We Had a Vaccine that Prevents Neisseria gonorrhoeae

enthalten in: The Journal of infectious diseases | 2024

von Cohen, M. | Marrazzo, J.

3

Author Correction : High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

enthalten in: Nature communications | 2024

von Reeves, D. | Mayer, B. | deCamp, A. | +30

ErratumFor: Nat Commun. 2023 Dec 14;14(1):8299. - PMID 38097552

4

In Memoriam : Dr. Adaora Alise Adimora

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Walensky, R. | Agwu, A. | Cohen, M.

5

Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Juraska, M. | Bai, H. | deCamp, A. | +39

6

Web Exclusive. Annals On Call - COVID-19 Rebound After Nirmatrelvir-Ritonavir Treatment

enthalten in: Annals of internal medicine | 2024

von Centor, R. | Cohen, M.

7

Demographics of sources of HIV-1 transmission in Zambia : a molecular epidemiology analysis in the HPTN 071 PopART study

enthalten in: The Lancet. Microbe | 2024

von Hall, M. | Golubchik, T. | Bonsall, D. | +86

8

Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy

enthalten in: Annals of internal medicine | 2023

von Cohen, M. | Brown, E.

CommentOn: Ann Intern Med. 2023 Dec;176(12):1577-1585. - PMID 37956428

9

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

10

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

enthalten in: Nature communications | 2023

von Reeves, D. | Mayer, B. | deCamp, A. | +30

ErratumIn: Nat Commun. 2024 Mar 22;15(1):2575. - PMID 38519455

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[63]